Page last updated: 2024-11-10
glycerophosphoserine
Description
glycerophosphoserine: RN given refers to (L-serine)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
glycerol 1-phosphoserine : A L-serine derivative consisting of L-serine having a 1-glycerophospho group attached to the side-chain hydroxy function. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
Synonyms (15)
Synonym |
l-serine, 2,3-dihydroxypropyl hydrogen phosphate (ester) |
glycerophosphoserine |
l-serine 2,3-dihydroxypropyl hydrogen phosphate |
1-glycerophosphoserine |
glycerol 1-phosphoserine |
o-[(2,3-dihydroxypropoxy)(hydroxy)phosphoryl]-l-serine |
CHEBI:62013 |
l-serine 1-phosphoglycerol |
glycero-1-phosphoserine |
26289-09-8 |
glycerylphosphoserine |
Q27131526 |
C22237 |
o-[(2,3-dihydroxypropoxy)(hydroxy)phosphoryl]serine |
DTXSID60949148 |
Research Excerpts
Toxicity
Drug Classes (3)
Class | Description |
glycerol 1-phosphodiester | A monoester of glycerophosphoric acid where R is an organyl group. |
L-serine derivative | A proteinogenic amino acid derivative resulting from reaction of L-serine at the amino group or the carboxy group, or from the replacement of any hydrogen of L-serine by a heteroatom. |
non-proteinogenic L-alpha-amino acid | Any L-alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (11)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 6 (54.55) | 29.6817 |
2010's | 2 (18.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 21.32
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 21.32 (24.57) | Research Supply Index | 2.48 (2.92) | Research Growth Index | 4.51 (4.65) | Search Engine Demand Index | 18.60 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 2 (18.18%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (81.82%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |